Dec. 26, 2023
by Andrii Buvailo
Biopharma insight
In the current climate of global economic uncertainty, one area of pharmaceutical development is bucking the trend with a significant …
Receptor.AI has announced ArtiDock, the best-in-class model for “AI docking," which predicts the binding poses of small molecule ligands in protein …
Nov. 27, 2023
by Andrii Buvailo
Biopharma insight
In recent news, Recursion (NASDAQ: RXRX), a prominent clinical stage TechBio firm, has announced the signing of agreements to acquire …
Nov. 17, 2023
by Andrii Buvailo
Biopharma insight
Companies are increasingly turning to generative artificial intelligence (AI) to develop new therapeutics, giving biotech companies with patents on these …
Nov. 7, 2023
by Tim Sandle
Biopharma insight
The digital transformation of biopharmaceutical manufacturing has continued at a rapid pace as companies mine the rich sources of data …
Nov. 3, 2023
by Andrii Buvailo
Biopharma insight
The first biologics drug, humanized insulin (5.8 kDa), became available in 1982 following the advent of biotechnology, and it marked …
Oct. 20, 2023
by Andrii Buvailo
Biopharma insight
It is hard to overestimate the potential of biotechnology to address some of the most pressing challenges of the 21st …
Sept. 13, 2023
by Andrii Buvailo
Interview
Biotechnology is more than just an emerging scientific frontier, it also impacts global economy, competition, and societal transformation. To learn …
Aug. 1, 2023
by Andrii Buvailo
Biopharma insight
As the global pharmaceutical landscape continues to transform at a breathtaking pace, it becomes crucial to examine the phenomenon that …
July 26, 2023
by Andrii Buvailo
Biopharma insight
AI in Drug Discovery at a Glance The ongoing rise of artificial intelligence (AI) is significantly impacting various industries, with …
July 14, 2023
by Andrii Buvailo
Biopharma insight
Since the early days of the pharmaceutical industry, small molecules have been the most extensively used group of drugs. Nowadays, …
July 11, 2023
by Andrii Buvailo
Biopharma insight
(Last updated: July 2023) Pharmaceutical companies are increasingly outsourcing research activities to academic institutions, tech-driven companies, and private contract research …